HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modulation of multidrug resistance in cancer cells by chelidonine and Chelidonium majus alkaloids.

Abstract
Cancer cells often develop multidrug resistance (MDR) which is a multidimensional problem involving several mechanisms and targets. This study demonstrates that chelidonine and an alkaloid extract from Chelidonium majus, which contains protoberberine and benzo[c]phenanthridine alkaloids, has the ability to overcome MDR of different cancer cell lines through interaction with ABC-transporters, CYP3A4 and GST, by induction of apoptosis, and cytotoxic effects. Chelidonine and the alkaloid extract inhibited P-gp/MDR1 activity in a concentration-dependent manner in Caco-2 and CEM/ADR5000 and reversed their doxorubicin resistance. In addition, chelidonine and the alkaloid extract inhibited the activity of the drug modifying enzymes CYP3A4 and GST in a dose-dependent manner. The alkaloids induced apoptosis in MDR cells which was accompanied by an activation of caspase-3, -8,-6/9, and phosphatidyl serine (PS) exposure. cDNA arrays were applied to identify differentially expressed genes after treatment with chelidonine and the alkaloid extract. The expression analysis identified a common set of regulated genes related to apoptosis, cell cycle, and drug metabolism. Treatment of Caco-2 cells with 50 μg/ml alkaloid extract and 50 μM chelidonine for up to 48 h resulted in a significant decrease in mRNA levels of P-gp/MDR1, MRP1, BCRP, CYP3A4, GST, and hPXR and in a significant increase in caspase-3 and caspase-8 mRNA. Thus, chelidonine is a promising model compound for overcoming MDR and for enhancing cytotoxicity of chemotherapeutics, especially against leukaemia cells. Its efficacy needs to be confirmed in animal models.
AuthorsMahmoud Zaki El-Readi, SafaaYehia Eid, Mohamed Lotfy Ashour, Ahmad Tahrani, Michael Wink
JournalPhytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine) Vol. 20 Issue 3-4 Pg. 282-94 (Feb 15 2013) ISSN: 1618-095X [Electronic] Germany
PMID23238299 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Validation Study)
CopyrightCrown Copyright © 2012. Published by Elsevier GmbH. All rights reserved.
Chemical References
  • ATP-Binding Cassette Transporters
  • Alkaloids
  • Antibiotics, Antineoplastic
  • Benzophenanthridines
  • Cytochrome P-450 CYP3A Inhibitors
  • Drugs, Chinese Herbal
  • Plant Extracts
  • Doxorubicin
  • chelidonine
  • Cytochrome P-450 CYP3A
  • CYP3A4 protein, human
  • Glutathione Transferase
  • Caspases
Topics
  • ATP-Binding Cassette Transporters (antagonists & inhibitors)
  • Alkaloids (chemistry)
  • Antibiotics, Antineoplastic
  • Apoptosis (drug effects)
  • Benzophenanthridines (pharmacology)
  • Caspases (metabolism)
  • Cell Line, Tumor
  • Chelidonium (chemistry)
  • Chromatography, Liquid
  • Cytochrome P-450 CYP3A
  • Cytochrome P-450 CYP3A Inhibitors
  • Doxorubicin
  • Drug Resistance, Multiple (drug effects)
  • Drug Resistance, Neoplasm (drug effects)
  • Drug Screening Assays, Antitumor
  • Drug Synergism
  • Drugs, Chinese Herbal (pharmacology)
  • Enzyme Activation (drug effects)
  • Gene Expression Profiling
  • Glutathione Transferase (antagonists & inhibitors)
  • Humans
  • Mass Spectrometry
  • Oligonucleotide Array Sequence Analysis
  • Plant Extracts (chemistry)
  • Real-Time Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: